Literature DB >> 23529455

Prescribing for older people with chronic renal impairment.

J Simon Bell1, Natalie Blacker, V Tammy Leblanc, Christopher P Alderman, Adam Phillips, Debra Rowett, Simone Rossi, Oliver Frank, Alan Husband.   

Abstract

BACKGROUND: Renal function is an important prescribing consideration. On average, glomerular filtration rate declines by about 10 mL/min every 10 years after the age of 40. Renal impairment may cause medicines to accumulate or cause toxicity, especially if the medicine has a narrow therapeutic index.
OBJECTIVE: To present an overview of prescribing considerations in the primary care setting for patients with chronic renal impairment. DISCUSSION: Serum creatinine considered in isolation is not a reliable indicator of renal function. The estimated glomerular filtration rate provided in pathology reporting can alert prescribers to possible renal impairment and the need to consider dose adjustments. The Cockcroft-Gault equation should be used to adjust medicine doses. Renal function monitoring is recommended for patients using medicines that can impair renal function or cause nephrotoxicity (eg. NSAIDs, ACEIs, ARBs).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529455

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  7 in total

1.  Drug-related problems identified during geriatric medication review in the community pharmacy.

Authors:  Mounir Rhalimi; Alain Rauss; Eric Housieaux
Journal:  Int J Clin Pharm       Date:  2017-11-29

2.  Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.

Authors:  Aarati Khanal; Gregory M Peterson; Ronald L Castelino; Matthew D Jose
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

3.  Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.

Authors:  Yen-Chun Peng; Cheng-Li Lin; Hong-Zen Yeh; Chi-Sen Chang; Yu-Lin Wu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.

Authors:  Yi Yang; Kaisha C George; Wei-Feng Shang; Rui Zeng; Shu-Wang Ge; Gang Xu
Journal:  Drug Des Devel Ther       Date:  2017-04-24       Impact factor: 4.162

5.  Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease.

Authors:  Gilbert Lefèvre; Francesca Callegari; Sandro Gsteiger; Yuan Xiong
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

6.  Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study.

Authors:  Maxwell Ogochukwu Adibe; Patrick Chisom Ewelum; Kosisochi Chinwendu Amorha
Journal:  Pan Afr Med J       Date:  2017-11-03

7.  High-volume continuous venovenous hemodiafiltration plus resin hemoperfusion improves severe metformin-associated toxicity.

Authors:  Shuangxin Liu; Lixia Xu; Jianchao Ma; Renwei Huang; Ting Lin; Zhuo Li; Huabang Liang; Sijia Li; Ruizhao Li; Li Zhang; Yiming Tao; Zhilian Li; Yuanhan Chen; Zhiming Ye; Bin Zhang; Wenjian Wang; Houqing Xiao; Xinling Liang; Wei Shi
Journal:  J Diabetes Investig       Date:  2017-12-06       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.